Free Trial

BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts

$14.44 -0.98 (-6.36%)
(As of 12/20/2024 05:55 PM ET)

BioStem Technologies Latest Earnings Summary

Latest
Earnings Date
Nov. 12Estimated
Actual EPS
(Nov. 12)
$0.32 Beat By $0.01
Consensus EPS
(Nov. 12)
$0.31

BioStem Technologies posted Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.32, which topped the consensus estimate of $0.31 by $0.01. Quarterly revenue was reported to be $82.56 million, above the consensus estimate of $78.22 million. With a trailing EPS of $0.68 and a P/E Ratio of 21.24, BioStem Technologies' earnings are expected to grow 62.41% next year, from $1.41 to $2.29 per share.

Get BioStem Technologies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioStem Technologies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BSEM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BSEM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioStem Technologies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.74$0.74$0.74
Q2 20241$0.77$0.77$0.77
Q3 20241$0.36$0.36$0.36
Q4 20241$0.37$0.37$0.37
FY 20244$2.24$2.24$2.24
Q1 20251$0.79$0.79$0.79
Q2 20251$0.80$0.80$0.80
Q3 20251$0.80$0.80$0.80
Q4 20251$0.81$0.81$0.81
FY 20254$3.20$3.20$3.20
Q1 20261$0.52$0.52$0.52
Q2 20261$0.57$0.57$0.57
Q3 20261$0.61$0.61$0.61

BioStem Technologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024-$0.31$0.32+$0.01$0.32$78.22M$82.56M
8/12/2024Q2 2024$0.12$0.30+$0.18$0.30$43.99M$74.49M
5/14/2024Q1 2024$0.74$0.20 -$0.54$0.20$12.70M$41.90M
4/1/2024Q4 2023--$0.14 -$0.14-$0.14$11.40M$11.44M
11/13/2023Q3 2023-$0.18$0.03+$0.21$0.03$1.39M$3.60M

BioStem Technologies Earnings - Frequently Asked Questions

BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on BSEM's earnings history.

In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.01. Learn more on analysts' earnings estimate vs. BSEM's actual earnings.

The conference call for BioStem Technologies's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BioStem Technologies's latest earnings report can be read online.
Read Transcript

BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $16.68 million.

BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 21.24 and a forward price-to-earnings ratio of 10.24.

BioStem Technologies's earnings are expected to grow from $1.41 per share to $2.29 per share in the next year, which is a 62.41% increase.

More Earnings Resources from MarketBeat



This page (OTCMKTS:BSEM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners